Correa, Arlene M.
The University of Texas MD Anderson Cancer Center
3 papers on CoChatORCID 0009-0001-8495-6602
Most cited papers
- Verified
Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy
Pataer, A., Kalhor, N., Correa, A. M., Raso, M. G., Erasmus, J. J., Kim, E. S., Behrens, C., Lee, J. J., Roth, J. A., Stewart, D. J., et al. (2012) · Journal of Thoracic Oncology
Lung Cancer Diagnosis and TreatmentLung Cancer Research Studies
Cited by 374
- Verified
Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small Cell Lung Cancer after Neoadjuvant Chemotherapy
William, W. N., Pataer, A., Kalhor, N., Correa, A. M., Rice, D. C., Wistuba, I. I., Heymach, J., Lee, J. J., Kim, E. S., Munden, R., et al. (2013) · Journal of Thoracic Oncology
Lung Cancer Diagnosis and TreatmentMedical Imaging Techniques and Applications
Cited by 138
- Verified
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
Weissferdt, A., Pataer, A., Vaporciyan, A. A., Correa, A. M., Sepesi, B., Moran, C. A., Wistuba, I. I., Roth, J. A., Shewale, J. B., Heymach, J. V., et al. (2020) · Clinical Lung Cancer
Lung Cancer Diagnosis and TreatmentLung Cancer Research Studies
Cited by 113
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free